User profiles for "author:D Bauerschlag"
Dirk BauerschlagProfessor of Medicine Verified email at uksh.de Cited by 3344 |
[HTML][HTML] Aging of blood can be tracked by DNA methylation changes at just three CpG sites
Background Human aging is associated with DNA methylation changes at specific sites in
the genome. These epigenetic modifications may be used to track donor age for forensic …
the genome. These epigenetic modifications may be used to track donor age for forensic …
Molecular and prognostic distinction between serous ovarian carcinomas of varying grade and malignant potential
I Meinhold-Heerlein, D Bauerschlag, F Hilpert… - Oncogene, 2005 - nature.com
Profiles of gene transcription have begun to delineate the molecular basis of ovarian cancer,
including distinctions between carcinomas of differing histology, tumor progression and …
including distinctions between carcinomas of differing histology, tumor progression and …
[HTML][HTML] Fatty acid synthase overexpression: target for therapy and reversal of chemoresistance in ovarian cancer
DO Bauerschlag, N Maass, P Leonhardt… - Journal of translational …, 2015 - Springer
Background Fatty acid synthase (FASN) is crucial to de novo long-chain fatty acid synthesis,
needed to meet cancer cells' increased demands for membrane, energy, and protein …
needed to meet cancer cells' increased demands for membrane, energy, and protein …
[HTML][HTML] One-step nucleic acid amplification—a molecular method for the detection of lymph node metastases in breast cancer patients; results of the German study …
C Schem, N Maass, DO Bauerschlag, MH Carstensen… - Virchows Archiv, 2009 - Springer
Sentinel lymph node (SN) biopsy is part of the staging procedure in breast cancer patients.
In this study, we compared an intraoperative tool named one-step nucleic acid amplification …
In this study, we compared an intraoperative tool named one-step nucleic acid amplification …
[HTML][HTML] Tribody [(HER2) 2xCD16] is more effective than trastuzumab in enhancing γδ T cell and natural killer cell cytotoxicity against HER2-expressing cancer cells
…, D Gonnermann, S Sebens, D Bauerschlag… - Frontiers in …, 2018 - frontiersin.org
An enhanced expression of human epidermal growth factor receptor 2 (HER2, ErbB2) often
occurs in an advanced stage of breast, ovarian, gastric or esophageal cancer, and …
occurs in an advanced stage of breast, ovarian, gastric or esophageal cancer, and …
Maternal and fetal cord blood lipids in intrauterine growth restriction
U Pecks, M Brieger, B Schiessl, DO Bauerschlag… - 2012 - degruyter.com
Aim: Small for gestational age neonates (SGA) could be subdivided into two groups
according to the underlying causes leading to low birth weight. Intrauterine growth restriction …
according to the underlying causes leading to low birth weight. Intrauterine growth restriction …
[HTML][HTML] Challenges in the diagnosis and individualized treatment of cervical cancer
M Schubert, DO Bauerschlag, MZ Muallem, N Maass… - Medicina, 2023 - mdpi.com
Cervical cancer is still the fourth most common cancer in women throughout the world; an
estimated 604,000 new cases were observed in 2020. Better knowledge of its pathogenesis …
estimated 604,000 new cases were observed in 2020. Better knowledge of its pathogenesis …
Evaluation of the effects of sensorimotor exercise on physical and psychological parameters in breast cancer patients undergoing neurotoxic chemotherapy
…, C Mundhenke, N Maass, D Bauerschlag… - Journal of cancer …, 2018 - Springer
Introduction Breast cancer is the most common cancer disease of women in industrialized
countries. Neurotoxic chemotherapy drugs are known to harm peripheral nerves and cause …
countries. Neurotoxic chemotherapy drugs are known to harm peripheral nerves and cause …
[HTML][HTML] A phase II trial (AGO 2.11) in platinum-resistant ovarian cancer: a randomized multicenter trial with sunitinib (SU11248) to evaluate dosage, schedule …
…, B Richter, K Wollschlaeger, T Dewitz, D Bauerschlag… - Annals of oncology, 2012 - Elsevier
Background Recurrent platinum-resistant ovarian cancer usually has a poor outcome with
conventional chemotherapeutic therapy and new treatment modalities are warranted. This …
conventional chemotherapeutic therapy and new treatment modalities are warranted. This …
Primary pulmonary choriocarcinoma: case report and review of the literature
J Serno, F Zeppernick, J Jäkel, S Schrading… - Gynecologic and …, 2012 - karger.com
Primary pulmonary choriocarcinoma is a rare disease with only 31 reported cases in the
literature so far. Here, we summarize all published cases, including a recent case of our own …
literature so far. Here, we summarize all published cases, including a recent case of our own …